Related references
Note: Only part of the references are listed.Direct measurement of hypoxia in a xenograft multiple myeloma model by optical-resolution photoacoustic microscopy
Toru Imai et al.
CANCER BIOLOGY & THERAPY (2017)
Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform
Yilin Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
Elizabeth Fox et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
The role of P-glycoprotein in drug resistance in multiple myeloma
Joseph Abraham et al.
LEUKEMIA & LYMPHOMA (2015)
Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance
Gergely Szakacs et al.
CHEMICAL REVIEWS (2014)
HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein
Jianfang Chen et al.
PLOS ONE (2014)
Hypoxia promotes stem cell-like phenotype in multiple myeloma cells
B. Muz et al.
BLOOD CANCER JOURNAL (2014)
Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1
Teresa S. Hawley et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1® in Combination With Paclitaxel in Solid Tumors
Ronan J. Kelly et al.
ONCOLOGIST (2012)
A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer
Ronan J. Kelly et al.
CLINICAL CANCER RESEARCH (2011)
Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein
Zsolt Bikadi et al.
PLOS ONE (2011)
Pharmacoinformatic Approaches to Design Natural Product Type Ligands of ABC-Transporters
F. Klepsch et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2009)
Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myeloma
D. Gutman et al.
LEUKEMIA (2009)
Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors
Holger Rumpold et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Benjamin J. Moeller et al.
CANCER AND METASTASIS REVIEWS (2007)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Knockdown of hypoxia-inducible factor-1α in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate
J Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Immunosuppressors and reversion of multidrug-resistance
N Aouali et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Proteasome inhibitor therapy in multiple myeloma
D Chauhan et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy
J Walker et al.
EUROPEAN JOURNAL OF CANCER (2004)
Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin
M Sugie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
AM Shannon et al.
CANCER TREATMENT REVIEWS (2003)
The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice
G Lehne et al.
LEUKEMIA (2002)
Share Paper
